EU Post-Market Registry to Collect Real-World Clinical Data on the Use of the Histolog Scanner.
A Prospective, Observational, Post-Market Registry to Collect Real-World Clinical Data on the Use of the Histolog Scanner in Multiple Disease Areas.
SamanTree Medical SA
5,000 participants
Mar 4, 2026
OBSERVATIONAL
Conditions
Summary
The goal of this observational study is to gather real-world evidence on the performance and safety of the Histolog® Scanner (HLS) when used as intended. HLS is a real-time ex-vivo tissue imaging device.
Eligibility
Inclusion Criteria3
- Age ≥18 years old at the time of consenting
- Undergoing a surgery or a medical procedure with use of Histolog® Scanner
- Ability to understand and the willingness to sign a written informed consent.
Exclusion Criteria2
- Active participation in a drug, device, or other medical intervention study that has not reached its primary endpoint at the time of consenting
- Patients under judicial protection, legal guardianship or curatorship.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Histolog Scanner intended to allow imaging of the internal microstructure of tissues including, but not limited to, the identification of cells, vessels and their organization or architecture.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07006090